ALS LIMITED (ALQ)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ALQ

ALQ - ALS LIMITED

Year End: March
GICS Industry Group : Commercial & Professional Services
Debt/EBITDA: 2.97
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

ALS Ltd provides laboratory and testing services across the mining, industrial and life sciences sector. It operates in over 65 countries. Formerly Campbell Brothers Ltd it first listed in 1952 and changed name to ALS in 2012.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$16.44

05 Jun
2025

0.240

OPEN

$16.26

1.48%

HIGH

$16.58

1,458,298

LOW

$16.22

TARGET
$18.73 13.9% upside
Franking for last dividend paid out: 30%
OTHER COMPANIES IN THE SAME SECTOR
3DA . AVD . BOL . BSA . CG1 . CLG . CVL . CWY . CXL . DOW . DUR . EGL . EGN . EVS . FLC . IPG . LBL . MAD . PPK . RWL . SDV . SHA . SND . SSM . SYL . VEE . VNT .
FNARENA'S MARKET CONSENSUS FORECASTS
ALQ: 1
Title FY24
Actual
FY25
Actual
FY26
Forecast
FY27
Forecast
EPS (cps) xxx 52.9 73.0 xxx
DPS (cps) xxx 38.6 44.0 xxx
EPS Growth xxx 100.0% 38.0% xxx
DPS Growth xxx - 1.5% 14.0% xxx
PE Ratio xxx N/A 22.5 xxx
Dividend Yield xxx N/A 2.7% xxx
Div Pay Ratio(%) xxx 73.0% 60.3% xxx

Dividend yield today if purchased 3 years ago: 3.05%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

2.35

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 27/11 - ex-div 18.90c (franking 30%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx52.9
DPS All xxxxxxxxxxxxxxx38.6
Sales/Revenue xxxxxxxxxxxxxxx2,999.4 M
Book Value Per Share xxxxxxxxxxxxxxx263.9
Net Operating Cash Flow xxxxxxxxxxxxxxx416.6 M
Net Profit Margin xxxxxxxxxxxxxxx8.54 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx20.80 %
Return on Invested Capital xxxxxxxxxxxxxxx8.62 %
Return on Assets xxxxxxxxxxxxxxx6.52 %
Return on Equity xxxxxxxxxxxxxxx20.80 %
Return on Total Capital xxxxxxxxxxxxxxx14.58 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx74.5 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx164 M
Long Term Debt xxxxxxxxxxxxxxx1,929 M
Total Debt xxxxxxxxxxxxxxx2,093 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx268 M
Price To Book Value xxxxxxxxxxxxxxx5.84

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx165.0 M
Capex % of Sales xxxxxxxxxxxxxxx5.50 %
Cost of Goods Sold xxxxxxxxxxxxxxx2,058 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx471 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx37 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.9

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

1

xxxxxx xx xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Bell Potter

28/05/2025

1

Buy

$19.70

19.83%

ALS Ltd's FY25 final partially franked dividend of 19.7c was in line with Bell Potter's expectations, and underlying net profit came within the previously flagged range.

The focus was on the outlook, with the group's organic growth forecast of 5-7% for FY26 falling short of the broker's 7.9% forecast. The company expects EBIT margin to expand, and the broker is forecasting a rise of 97bps vs -185bps in FY25.

The analyst notes the company is on track to achieve its FY27 targets

Institutional equity placement of $350m is planned, with up to $40m additional flagged via SPP, and $230m will be invested for capacity expansion. The broker adjusted forecasts to account for higher capex and equity raising, lower interest rate expense and life science EBIT expectations in FY26-27.

Buy. Target cut to $19.70 from $20.00.

FORECAST
Bell Potter forecasts a full year FY26 dividend of 44.90 cents and EPS of 74.60 cents.
Bell Potter forecasts a full year FY27 dividend of 51.20 cents and EPS of 84.60 cents.

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

02/06/2025

4

Underweight

$14.60

-11.19%

ALS Ltd reported FY25 profit of $312m, in line with guidance and consensus, notes Jarden. Life Sciences showed strong cost control, while Commodities delivered a better second half despite weaker pricing.

A $390m equity raise was announced, which the broker views as dilutive and unnecessary given existing funding capacity.

FY26 guidance implies to the analysts modest growth, with second-half skew and ongoing pricing pressure in Geochemistry.

Jarden cuts its EPS forecasts by up to -3.2% through FY28 due to mix and cost concerns. The target price falls to $14.60 from $15.00. Underweight rating.

FORECAST
Jarden forecasts a full year FY26 dividend of 42.20 cents and EPS of 71.40 cents.
Jarden forecasts a full year FY27 dividend of 49.00 cents and EPS of 81.60 cents.

ALQ STOCK CHART